Pharvaris Statistics
Total Valuation
Pharvaris has a market cap or net worth of $2.48 billion. The enterprise value is $2.12 billion.
| Market Cap | 2.48B |
| Enterprise Value | 2.12B |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharvaris has 70.20 million shares outstanding. The number of shares has increased by 19.89% in one year.
| Current Share Class | 70.20M |
| Shares Outstanding | 70.20M |
| Shares Change (YoY) | +19.89% |
| Shares Change (QoQ) | +4.24% |
| Owned by Insiders (%) | 2.72% |
| Owned by Institutions (%) | 63.46% |
| Float | 43.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 1,095.31 |
| PB Ratio | 7.22 |
| P/TBV Ratio | 7.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.94, with a Debt / Equity ratio of 0.00.
| Current Ratio | 11.94 |
| Quick Ratio | 11.82 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,054.74 |
Financial Efficiency
Return on equity (ROE) is -70.46% and return on invested capital (ROIC) is -46.85%.
| Return on Equity (ROE) | -70.46% |
| Return on Assets (ROA) | -42.32% |
| Return on Invested Capital (ROIC) | -46.85% |
| Return on Capital Employed (ROCE) | -60.51% |
| Weighted Average Cost of Capital (WACC) | -8.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.32M |
| Employee Count | 148 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharvaris has paid $2.69 million in taxes.
| Income Tax | 2.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.53% in the last 52 weeks. The beta is -2.33, so Pharvaris's price volatility has been lower than the market average.
| Beta (5Y) | -2.33 |
| 52-Week Price Change | +48.53% |
| 50-Day Moving Average | 34.59 |
| 200-Day Moving Average | 29.27 |
| Relative Strength Index (RSI) | 49.96 |
| Average Volume (20 Days) | 654,606 |
Short Selling Information
The latest short interest is 1.78 million, so 2.53% of the outstanding shares have been sold short.
| Short Interest | 1.78M |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 2.53% |
| Short % of Float | 4.06% |
| Short Ratio (days to cover) | 3.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -208.30M |
| Pretax Income | -192.58M |
| Net Income | -195.27M |
| EBITDA | -208.12M |
| EBIT | -208.30M |
| Earnings Per Share (EPS) | -$2.99 |
Balance Sheet
The company has $363.63 million in cash and $769,711 in debt, with a net cash position of $362.86 million or $5.17 per share.
| Cash & Cash Equivalents | 363.63M |
| Total Debt | 769,711 |
| Net Cash | 362.86M |
| Net Cash Per Share | $5.17 |
| Equity (Book Value) | 343.67M |
| Book Value Per Share | 4.90 |
| Working Capital | 342.17M |
Cash Flow
In the last 12 months, operating cash flow was -$179.78 million and capital expenditures -$114,983, giving a free cash flow of -$179.89 million.
| Operating Cash Flow | -179.78M |
| Capital Expenditures | -114,983 |
| Depreciation & Amortization | 182,664 |
| Net Borrowing | -248,789 |
| Free Cash Flow | -179.89M |
| FCF Per Share | -$2.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Pharvaris does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.89% |
| Shareholder Yield | -19.89% |
| Earnings Yield | -7.88% |
| FCF Yield | -7.25% |
Analyst Forecast
The average price target for Pharvaris is $49.47, which is 40.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.47 |
| Price Target Difference | 40.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |